Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

No experimental data are available regarding the toxicokinetic behavior and metabolism of the test substance.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential

Additional information

No experimental data are available regarding the toxicokinetic behavior and metabolism of the test substance.

Due to its low water solubility and relatively large particle size, phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide is considered to have low oral/ gastrointestinal absorption. It is expected this substance has no or very limited potential to be inhaled since it is insoluble in water, has low volatility and low vapour pressure. Based on the expected kinetic behaviour in the body, there is sufficient evidence that dermal absorption takes place and it is expected that uptake into the stratum corneum will be high. However, as there is no evidence of systemic toxicity in the 28-day oral toxicity study, the substance will likely not pass through the outer skin layer and hence, it will not pass through the rest of the skin and not enter the circulation. Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide will hardly be absorbed after oral and inhalation administration due to its hydrophobicity, relatively large particle size and low volatility as well as low vapour pressure.